Exclusive: RNA firm Eterna Therapeutics buys neighboring startup for $50M


An RNA firm called Eterna Therapeutics Inc. just bought its next-door neighbor for as much as $50 million.

Previous Hatteras-backed Durham startup aims to treat 'undruggable' cancer targets
Next Target Field to host The Killers, Imagine Dragons at new TC Summer Fest